CD4 and Parkinson disease: In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson’s disease (PD) mouse model, EGCG could increase the ratio of CD3+CD4+ to CD3+CD8+ T lymphocytes and modulate peripheral immune response [42].